Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative hormonal treatment for endometriosis before laparoscopic excision
ACTRN12605000558628Phase 4Recruiting
- Sponsor
- Department of EndoGynaecology, Royal Hospital for Women
- Start
- Jan 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of drospirenone + ethinyl estradiol and Placebo-COD Research Private Ltd in endometriosis (3 arms), sponsored by Department of EndoGynaecology, Royal Hospital for Women. Primary endpoints: Pain score by visual analogue scale, Pain change by McGill Pain Questionnaire and 1 more. Started Jan 2002; status: recruiting.
02
Drugs
drospirenone + ethinyl estradiolPlacebo-COD Research Private Ltd
03
Conditions
endometriosis
Beyond the preview
Go deeper on ACTRN12605000558628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12605000558628.